Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль

Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0
ClinicalTrialUtilities: обзор

Галерея

Timeline of Selected FDA Activities and Significant Events Addressing Opioid Misuse and Abuse
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-10-04 By FDA
Cervarix
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-10-04 By FDA
FDA Health Playbook
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
CBER Vaccine ICSR (Legacy) Implementation
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-10-04 By FDA
BEXSERO
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-10-04 By FDA
Generic Drug Facilities, Sites and Organization Lists
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
Fluorouracil and Pet Safety
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
FDA Approves New Treatment Option for Patients with ALS
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
El fluorouracilo y la seguridad de las mascotas
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
Patent Certifications and Suitability Petitions
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
CDERLearn Training and Education
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
Designating an Orphan Product: Drugs and Biological Products
Source: FDA - What's New: Drugs RSS Feed Published on 2022-10-04 By FDA
Human medicines European public assessment report (EPAR): Intuniv, guanfacine, Attention Deficit Disorder with Hyperactivity, Date of authorisation: 17/09/2015, Revision: 11, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-10-04

Предыдущие записи

Тема: Scaffold от Danny Cooper.